Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUGAR-DIP trial
2016-001401-16Phase 3Completed
- Sponsor
- Academic Medical Center
- Start
- Nov 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin, glibenclamide and human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Academic Medical Center. Primary endpoint: Rate of large-for-gestational-age infants. Started Nov 2016; status: completed.
02
Drugs
metforminglibenclamidehuman insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2016-001401-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001401-16.